NEUROLOGY
January 14, 2022
The Promise of Alpha-Adrenergics in Parkinson’s Disease
Neuroprotection has become a key target area for minimizing the risk or progression of the disorder, and these agents are believed to have a potential role in treatment given their mechanisms and effects on locus coeruleus cells and phosphoglycerate kinase 1.January 14, 2022
Correcting Dupuytren’s Contracture
January 14, 2022
Carbamazepine 25 mg/mL in SyrSpend SF PH4
January 14, 2022
Understanding and Managing Postural Orthostatic Tachycardia Syndrome
January 14, 2022
ADD/ADHD Prevalence and Treatment in Children
January 14, 2022
Alzheimer’s Disease and COVID-19 Share Genetic Risk Factor
January 14, 2022
Helping People Manage Insomnia
January 14, 2022
PTA: Amyotrophic Lateral Sclerosis
December 28, 2021
FDA Approves First and Only Ready-to-Use Topiramate Oral Solution
October 15, 2021
Azstarys in Ora-Blend Single Dose
October 15, 2021
New Drug Review 2021
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Take Quiz
Copyright © 2000 - 2022 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.